These Israeli pharmaceutical stocks are down in the wake of Hamas attack

TARODelisted Stock  USD 42.97  0.00  0.00%   
About 56% of Taro Pharmaceutical's investor base is looking to short. The analysis of current outlook of investing in Taro Pharmaceutical Industries suggests that many traders are alarmed regarding Taro Pharmaceutical's prospects. Taro Pharmaceutical's investing sentiment overview a quick insight into current market opportunities from investing in Taro Pharmaceutical Industries. Many technical investors use Taro Pharmaceutical stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
Shares of Israeli pharmaceutical giant Teva are down in premarket trades Monday following Hamas surprise attack over the weekend.

Read at marketwatch.com
marketwatch News
  

Taro Pharmaceutical Fundamental Analysis

We analyze Taro Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Taro Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Taro Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Outstanding

Shares Outstanding Comparative Analysis

Taro Pharmaceutical is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Taro Pharmaceutical Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Taro Pharmaceutical stock to make a market-neutral strategy. Peer analysis of Taro Pharmaceutical could also be used in its relative valuation, which is a method of valuing Taro Pharmaceutical by comparing valuation metrics with similar companies.

Peers

Taro Pharmaceutical Related Equities

RDHLRedhill Biopharma   6.78   
0%
100.0%
PCRXPacira BioSciences,   1.62   
0%
23.0%
PBHPrestige Brand   0.71   
0%
10.0%
RDYDr Reddys   0.43   
0%
6.0%
AMPHAmphastar   0.04   
1.0%
0%
COLLCollegium Pharmaceutical   0.68   
10.0%
0%
ORGOOrganogenesis Holdings   0.77   
11.0%
0%
PAHCPhibro Animal   0.93   
13.0%
0%
SUPNSupernus Pharmaceuticals   1.14   
16.0%
0%
LFCRLifecore Biomedical   1.20   
17.0%
0%
EVOEvotec SE   2.90   
42.0%
0%
ANIPANI Pharmaceuticals   3.64   
53.0%
0%
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Consideration for investing in Taro Stock

If you are still planning to invest in Taro Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Taro Pharmaceutical's history and understand the potential risks before investing.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
CEOs Directory
Screen CEOs from public companies around the world
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments